WHO Grade 1 Glioma — Trials

WHO Grade 1 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

36 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04166409	A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma	recruiting	Phase 3	170	National Cancer Institute (NCI)NIH	3	Sep 11, 2026	clinicaltrials
NCT04576117	A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma	active not recruiting	Phase 3	300	National Cancer Institute (NCI)NIH	2	Jul 2, 2026	clinicaltrials
NCT00789828	Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)(EXIST-1)	completed	Phase 3	117	Novartis PharmaceuticalsINDUSTRY	10	Feb 3, 2016	clinicaltrials

Data updated 19 days agoSource updated Sep 11, 2026source: clinicaltrials